| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | peptidyltransferase activity | 7.38e-06 | 6 | 145 | 3 | GO:0000048 | |
| GeneOntologyMolecularFunction | leukotriene-C(4) hydrolase | 7.38e-06 | 6 | 145 | 3 | GO:0002951 | |
| GeneOntologyMolecularFunction | dipeptidase activity | 7.54e-06 | 18 | 145 | 4 | GO:0016805 | |
| GeneOntologyMolecularFunction | exopeptidase activity | 1.57e-05 | 110 | 145 | 7 | GO:0008238 | |
| GeneOntologyMolecularFunction | leukotriene C4 gamma-glutamyl transferase activity | 2.05e-05 | 8 | 145 | 3 | GO:0103068 | |
| GeneOntologyMolecularFunction | glutathione hydrolase activity | 3.05e-05 | 9 | 145 | 3 | GO:0036374 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 4.48e-05 | 54 | 145 | 5 | GO:0001223 | |
| GeneOntologyMolecularFunction | L-alanine:2-oxoglutarate aminotransferase activity | 5.24e-05 | 2 | 145 | 2 | GO:0004021 | |
| GeneOntologyMolecularFunction | tetrahydrofolyl-poly(glutamate) polymer binding | 5.24e-05 | 2 | 145 | 2 | GO:1904493 | |
| GeneOntologyMolecularFunction | Ac-Asp-Glu binding | 5.24e-05 | 2 | 145 | 2 | GO:1904492 | |
| GeneOntologyMolecularFunction | alanine-oxo-acid transaminase activity | 5.24e-05 | 2 | 145 | 2 | GO:0047635 | |
| GeneOntologyMolecularFunction | filamin binding | 5.50e-05 | 29 | 145 | 4 | GO:0031005 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 7.06e-05 | 188 | 145 | 8 | GO:0005201 | |
| GeneOntologyMolecularFunction | metallocarboxypeptidase activity | 7.21e-05 | 31 | 145 | 4 | GO:0004181 | |
| GeneOntologyMolecularFunction | metalloexopeptidase activity | 1.56e-04 | 70 | 145 | 5 | GO:0008235 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 1.90e-04 | 73 | 145 | 5 | GO:0050840 | |
| GeneOntologyMolecularFunction | omega peptidase activity | 1.96e-04 | 16 | 145 | 3 | GO:0008242 | |
| GeneOntologyMolecularFunction | aminopeptidase activity | 2.64e-04 | 43 | 145 | 4 | GO:0004177 | |
| GeneOntologyMolecularFunction | threonine-type peptidase activity | 3.91e-04 | 20 | 145 | 3 | GO:0070003 | |
| GeneOntologyMolecularFunction | carboxypeptidase activity | 4.39e-04 | 49 | 145 | 4 | GO:0004180 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 5.58e-04 | 140 | 145 | 6 | GO:0001221 | |
| GeneOntologyMolecularFunction | laminin-1 binding | 1.42e-03 | 8 | 145 | 2 | GO:0043237 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 1.90e-03 | 34 | 145 | 3 | GO:0015125 | |
| GeneOntologyBiologicalProcess | sulfur amino acid biosynthetic process | 1.28e-05 | 21 | 145 | 4 | GO:0000097 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | DSCAM PSG1 PSG4 PCDHGA4 KIFAP3 CELSR1 PTPRG AMIGO3 PTPRS ROBO1 ROBO3 | 1.37e-05 | 313 | 145 | 11 | GO:0098742 |
| GeneOntologyBiologicalProcess | cysteine biosynthetic process | 1.86e-05 | 8 | 145 | 3 | GO:0019344 | |
| GeneOntologyBiologicalProcess | peptide modification | 3.94e-05 | 10 | 145 | 3 | GO:0031179 | |
| GeneOntologyBiologicalProcess | leukotriene D4 biosynthetic process | 3.94e-05 | 10 | 145 | 3 | GO:1901750 | |
| GeneOntologyBiologicalProcess | chemorepulsion involved in postnatal olfactory bulb interneuron migration | 4.91e-05 | 2 | 145 | 2 | GO:0021836 | |
| GeneOntologyBiologicalProcess | glutathione catabolic process | 5.39e-05 | 11 | 145 | 3 | GO:0006751 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 5.43e-05 | 187 | 145 | 8 | GO:0007156 | |
| GeneOntologyBiologicalProcess | leukotriene D4 metabolic process | 7.15e-05 | 12 | 145 | 3 | GO:1901748 | |
| GeneOntologyBiologicalProcess | postnatal olfactory bulb interneuron migration | 1.47e-04 | 3 | 145 | 2 | GO:0021827 | |
| GeneOntologyBiologicalProcess | cerebral cortex tangential migration using cell-cell interactions | 1.47e-04 | 3 | 145 | 2 | GO:0021823 | |
| GeneOntologyBiologicalProcess | substrate-dependent cerebral cortex tangential migration | 1.47e-04 | 3 | 145 | 2 | GO:0021825 | |
| GeneOntologyBiologicalProcess | sulfur amino acid metabolic process | 1.76e-04 | 40 | 145 | 4 | GO:0000096 | |
| GeneOntologyBiologicalProcess | cysteine metabolic process | 1.78e-04 | 16 | 145 | 3 | GO:0006534 | |
| GeneOntologyBiologicalProcess | kidney mesenchyme development | 1.78e-04 | 16 | 145 | 3 | GO:0072074 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 2.57e-04 | 18 | 145 | 3 | GO:1903385 | |
| GeneOntologyBiologicalProcess | L-alanine metabolic process | 2.92e-04 | 4 | 145 | 2 | GO:0042851 | |
| GeneOntologyBiologicalProcess | L-alanine catabolic process | 2.92e-04 | 4 | 145 | 2 | GO:0042853 | |
| GeneOntologyBiologicalProcess | regulation of negative chemotaxis | 2.92e-04 | 4 | 145 | 2 | GO:0050923 | |
| GeneOntologyBiologicalProcess | synapse assembly | 3.38e-04 | 308 | 145 | 9 | GO:0007416 | |
| GeneOntologyBiologicalProcess | proteinogenic amino acid metabolic process | 3.40e-04 | 185 | 145 | 7 | GO:0170039 | |
| GeneOntologyBiologicalProcess | glutathione biosynthetic process | 3.55e-04 | 20 | 145 | 3 | GO:0006750 | |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 2.08e-04 | 42 | 146 | 4 | GO:0070971 | |
| GeneOntologyCellularComponent | cell surface | HLA-B PSG1 PSG4 FOLH1 PSG7 RTP2 ADGRV1 CUBN THSD1 TFR2 SLIT2 SULF2 PXDN CNTNAP2 ABCB11 FOLH1B ROBO1 RORC EGFL7 | 2.74e-04 | 1111 | 146 | 19 | GO:0009986 |
| MousePheno | abnormal circulating glutathione level | 5.08e-06 | 5 | 113 | 3 | MP:0030652 | |
| MousePheno | increased circulating glutathione level | 5.08e-06 | 5 | 113 | 3 | MP:0030653 | |
| MousePheno | glutathionuria | 5.08e-06 | 5 | 113 | 3 | MP:0013730 | |
| MousePheno | increased glutathione level | 5.08e-06 | 5 | 113 | 3 | MP:0012606 | |
| MousePheno | decreased circulating cysteine level | 1.76e-05 | 7 | 113 | 3 | MP:0030626 | |
| MousePheno | absent estrous cycle | 2.67e-05 | 44 | 113 | 5 | MP:0009009 | |
| MousePheno | decreased cysteine level | 2.80e-05 | 8 | 113 | 3 | MP:0030623 | |
| MousePheno | epididymis hypoplasia | 2.80e-05 | 8 | 113 | 3 | MP:0004932 | |
| MousePheno | nervous | 4.17e-05 | 9 | 113 | 3 | MP:0008912 | |
| MousePheno | failure of copulatory plug deposition | 5.92e-05 | 10 | 113 | 3 | MP:0030983 | |
| MousePheno | seminal vesicle hypoplasia | 5.92e-05 | 10 | 113 | 3 | MP:0005148 | |
| MousePheno | ovary hypoplasia | 5.92e-05 | 10 | 113 | 3 | MP:0005158 | |
| MousePheno | abnormal circulating cysteine level | 8.10e-05 | 11 | 113 | 3 | MP:0030624 | |
| MousePheno | absent tertiary ovarian follicles | 8.10e-05 | 11 | 113 | 3 | MP:0011130 | |
| MousePheno | decreased circulating insulin-like growth factor I level | 1.31e-04 | 61 | 113 | 5 | MP:0004701 | |
| MousePheno | decreased amino acid level | 1.33e-04 | 97 | 113 | 6 | MP:0014528 | |
| MousePheno | abnormal cysteine level | 1.39e-04 | 13 | 113 | 3 | MP:0030621 | |
| MousePheno | decreased glutathione level | 1.39e-04 | 13 | 113 | 3 | MP:0012604 | |
| MousePheno | abnormal glutathione level | 1.39e-04 | 13 | 113 | 3 | MP:0012603 | |
| MousePheno | priapism | 1.75e-04 | 14 | 113 | 3 | MP:0003415 | |
| MousePheno | abnormal copulatory plug deposition | 2.67e-04 | 16 | 113 | 3 | MP:0030982 | |
| MousePheno | decreased spleen red pulp amount | 2.67e-04 | 16 | 113 | 3 | MP:0008477 | |
| MousePheno | abnormal circulating insulin-like growth factor I level | 2.87e-04 | 72 | 113 | 5 | MP:0004700 | |
| MousePheno | abnormal thyroid hormone level | 3.26e-04 | 74 | 113 | 5 | MP:0005468 | |
| MousePheno | abnormal insulin-like growth factor I level | 3.47e-04 | 75 | 113 | 5 | MP:0008831 | |
| MousePheno | failure of superovulation | 3.84e-04 | 18 | 113 | 3 | MP:0031422 | |
| MousePheno | abnormal penile erection | 3.84e-04 | 18 | 113 | 3 | MP:0001379 | |
| MousePheno | oocyte degeneration | 3.84e-04 | 18 | 113 | 3 | MP:0009093 | |
| MousePheno | heart vascular congestion | 3.85e-04 | 4 | 113 | 2 | MP:0010021 | |
| MousePheno | increased osteoclast cell number | 3.93e-04 | 77 | 113 | 5 | MP:0004984 | |
| MousePheno | thick pulmonary interalveolar septum | 4.28e-04 | 44 | 113 | 4 | MP:0001179 | |
| MousePheno | decreased follicle stimulating hormone level | 4.28e-04 | 44 | 113 | 4 | MP:0005130 | |
| MousePheno | increased circulating growth hormone level | 4.53e-04 | 19 | 113 | 3 | MP:0005123 | |
| MousePheno | abnormal copulation physiology | 4.53e-04 | 19 | 113 | 3 | MP:0031627 | |
| MousePheno | abnormal nervous system regeneration | 6.15e-04 | 21 | 113 | 3 | MP:0004858 | |
| MousePheno | decreased astrocyte number | 6.37e-04 | 5 | 113 | 2 | MP:0012066 | |
| MousePheno | small vertebrae | 7.08e-04 | 22 | 113 | 3 | MP:0004610 | |
| MousePheno | decreased thyroxine level | 7.55e-04 | 51 | 113 | 4 | MP:0005471 | |
| MousePheno | increased growth hormone level | 8.10e-04 | 23 | 113 | 3 | MP:0005137 | |
| MousePheno | abnormal T-helper 17 cell morphology | 8.10e-04 | 23 | 113 | 3 | MP:0010217 | |
| MousePheno | uterus hypoplasia | 8.10e-04 | 23 | 113 | 3 | MP:0001121 | |
| Domain | IGc2 | DSCAM PSG1 PSG4 PSG7 VSIG4 PAPLN CILP2 PXDN AMIGO3 PTPRS ICAM5 ROBO1 LSAMP ROBO3 | 2.97e-09 | 235 | 141 | 14 | SM00408 |
| Domain | Ig_sub2 | DSCAM PSG1 PSG4 PSG7 VSIG4 PAPLN CILP2 PXDN AMIGO3 PTPRS ICAM5 ROBO1 LSAMP ROBO3 | 2.97e-09 | 235 | 141 | 14 | IPR003598 |
| Domain | TFR_dimer | 4.61e-08 | 6 | 141 | 4 | PF04253 | |
| Domain | - | 4.61e-08 | 6 | 141 | 4 | 1.20.930.40 | |
| Domain | TFR-like_dimer_dom | 1.07e-07 | 7 | 141 | 4 | IPR007365 | |
| Domain | - | COL12A1 DSCAM HLA-B PSG1 PSG4 COL20A1 PSG7 VSIG4 PAPLN CILP2 PXDN PTPRG AMIGO3 PTPRS ICAM5 CD101 ROBO1 LSAMP ROBO3 TNXB | 1.31e-07 | 663 | 141 | 20 | 2.60.40.10 |
| Domain | Ig_I-set | DSCAM VSIG4 PAPLN CILP2 PXDN PTPRS ICAM5 CD101 ROBO1 LSAMP ROBO3 | 2.11e-07 | 190 | 141 | 11 | IPR013098 |
| Domain | I-set | DSCAM VSIG4 PAPLN CILP2 PXDN PTPRS ICAM5 CD101 ROBO1 LSAMP ROBO3 | 2.11e-07 | 190 | 141 | 11 | PF07679 |
| Domain | Ig-like_fold | COL12A1 DSCAM HLA-B PSG1 PSG4 COL20A1 PSG7 VSIG4 PAPLN CILP2 PXDN PTPRG AMIGO3 PTPRS ICAM5 CD101 ROBO1 LSAMP ROBO3 TNXB | 3.57e-07 | 706 | 141 | 20 | IPR013783 |
| Domain | IG | DSCAM PSG1 PSG4 PSG7 VSIG4 PAPLN CILP2 PXDN AMIGO3 PTPRS ICAM5 CD101 ROBO1 LSAMP ROBO3 | 7.07e-07 | 421 | 141 | 15 | SM00409 |
| Domain | Ig_sub | DSCAM PSG1 PSG4 PSG7 VSIG4 PAPLN CILP2 PXDN AMIGO3 PTPRS ICAM5 CD101 ROBO1 LSAMP ROBO3 | 7.07e-07 | 421 | 141 | 15 | IPR003599 |
| Domain | IG_LIKE | DSCAM HLA-B PSG1 PSG4 PSG7 VSIG4 PAPLN CILP2 PXDN AMIGO3 PTPRS ICAM5 CD101 ROBO1 LSAMP ROBO3 | 9.60e-07 | 491 | 141 | 16 | PS50835 |
| Domain | Ig-like_dom | DSCAM HLA-B PSG1 PSG4 PSG7 VSIG4 PAPLN CILP2 PXDN AMIGO3 PTPRS ICAM5 CD101 ROBO1 LSAMP ROBO3 | 1.32e-06 | 503 | 141 | 16 | IPR007110 |
| Domain | Peptidase_M28 | 1.47e-06 | 12 | 141 | 4 | PF04389 | |
| Domain | Peptidase_M28 | 1.47e-06 | 12 | 141 | 4 | IPR007484 | |
| Domain | FERM_M | 2.44e-05 | 46 | 141 | 5 | PF00373 | |
| Domain | fn3 | 3.21e-05 | 162 | 141 | 8 | PF00041 | |
| Domain | FERM_central | 3.33e-05 | 49 | 141 | 5 | IPR019748 | |
| Domain | FERM_domain | 3.33e-05 | 49 | 141 | 5 | IPR000299 | |
| Domain | FERM_1 | 3.68e-05 | 50 | 141 | 5 | PS00660 | |
| Domain | FERM_2 | 3.68e-05 | 50 | 141 | 5 | PS00661 | |
| Domain | FERM_3 | 3.68e-05 | 50 | 141 | 5 | PS50057 | |
| Domain | Band_41_domain | 3.68e-05 | 50 | 141 | 5 | IPR019749 | |
| Domain | B41 | 3.68e-05 | 50 | 141 | 5 | SM00295 | |
| Domain | Laminin_G | 7.59e-05 | 58 | 141 | 5 | IPR001791 | |
| Domain | FN3 | 8.22e-05 | 185 | 141 | 8 | SM00060 | |
| Domain | FERM_N | 1.07e-04 | 33 | 141 | 4 | IPR018979 | |
| Domain | FERM_N | 1.07e-04 | 33 | 141 | 4 | PF09379 | |
| Domain | ASX_HYDROXYL | 1.11e-04 | 100 | 141 | 6 | PS00010 | |
| Domain | FN3 | 1.36e-04 | 199 | 141 | 8 | PS50853 | |
| Domain | Ig_V-set | 1.36e-04 | 199 | 141 | 8 | IPR013106 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.53e-04 | 106 | 141 | 6 | IPR000152 | |
| Domain | FN3_dom | 1.91e-04 | 209 | 141 | 8 | IPR003961 | |
| Domain | IGv | 2.58e-04 | 75 | 141 | 5 | SM00406 | |
| Domain | ConA-like_dom | 2.62e-04 | 219 | 141 | 8 | IPR013320 | |
| Domain | EGF_CA | 3.28e-04 | 122 | 141 | 6 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 3.58e-04 | 124 | 141 | 6 | IPR001881 | |
| Domain | PA | 3.74e-04 | 19 | 141 | 3 | PF02225 | |
| Domain | PA_domain | 3.74e-04 | 19 | 141 | 3 | IPR003137 | |
| Domain | EGF | 3.90e-04 | 126 | 141 | 6 | PF00008 | |
| Domain | EGF | 4.20e-04 | 235 | 141 | 8 | SM00181 | |
| Domain | EGF_3 | 4.20e-04 | 235 | 141 | 8 | PS50026 | |
| Domain | - | 5.07e-04 | 49 | 141 | 4 | 1.20.80.10 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 5.48e-04 | 50 | 141 | 4 | IPR014352 | |
| Domain | ig | 6.06e-04 | 190 | 141 | 7 | PF00047 | |
| Domain | Immunoglobulin | 6.06e-04 | 190 | 141 | 7 | IPR013151 | |
| Domain | EGF-like_dom | 6.15e-04 | 249 | 141 | 8 | IPR000742 | |
| Domain | EGF_1 | 7.19e-04 | 255 | 141 | 8 | PS00022 | |
| Domain | FERM_CS | 7.59e-04 | 24 | 141 | 3 | IPR019747 | |
| Domain | - | 7.68e-04 | 95 | 141 | 5 | 2.60.120.200 | |
| Domain | DDHD | 8.32e-04 | 6 | 141 | 2 | PF02862 | |
| Domain | DDHD | 8.32e-04 | 6 | 141 | 2 | PS51043 | |
| Domain | DDHD_dom | 8.32e-04 | 6 | 141 | 2 | IPR004177 | |
| Domain | DDHD | 8.32e-04 | 6 | 141 | 2 | SM01127 | |
| Domain | EGF-like_CS | 8.36e-04 | 261 | 141 | 8 | IPR013032 | |
| Domain | EGF_Ca-bd_CS | 8.44e-04 | 97 | 141 | 5 | IPR018097 | |
| Domain | EGF_2 | 9.22e-04 | 265 | 141 | 8 | PS01186 | |
| Domain | EGF_CA | 9.25e-04 | 99 | 141 | 5 | PS01187 | |
| Domain | FERM_C | 9.64e-04 | 26 | 141 | 3 | PF09380 | |
| Domain | FERM_PH-like_C | 1.08e-03 | 27 | 141 | 3 | IPR018980 | |
| Domain | FERM_C | 1.08e-03 | 27 | 141 | 3 | SM01196 | |
| Domain | GGT_peptidase | 1.16e-03 | 7 | 141 | 2 | IPR000101 | |
| Domain | TB | 1.16e-03 | 7 | 141 | 2 | PF00683 | |
| Domain | G_glu_transpept | 1.16e-03 | 7 | 141 | 2 | PF01019 | |
| Domain | SIX1_SD | 1.16e-03 | 7 | 141 | 2 | IPR031701 | |
| Domain | G_GLU_TRANSPEPTIDASE | 1.16e-03 | 7 | 141 | 2 | PS00462 | |
| Domain | SIX1_SD | 1.16e-03 | 7 | 141 | 2 | PF16878 | |
| Domain | Growth_fac_rcpt_ | 1.20e-03 | 156 | 141 | 6 | IPR009030 | |
| Domain | PH_dom-like | NUMBL FRMPD1 MCF2L2 PLEKHA6 PTPN21 TIAM2 FARP2 NBEAL2 FRMPD3 EPB41L2 | 1.49e-03 | 426 | 141 | 10 | IPR011993 |
| Domain | DHC_N1 | 1.54e-03 | 8 | 141 | 2 | PF08385 | |
| Domain | - | 1.54e-03 | 8 | 141 | 2 | 3.90.290.10 | |
| Domain | Dynein_heavy_dom-1 | 1.54e-03 | 8 | 141 | 2 | IPR013594 | |
| Domain | TB_dom | 1.97e-03 | 9 | 141 | 2 | IPR017878 | |
| Domain | TB | 1.97e-03 | 9 | 141 | 2 | PS51364 | |
| Domain | GPS | 2.12e-03 | 34 | 141 | 3 | SM00303 | |
| Domain | Ig_2 | 2.26e-03 | 73 | 141 | 4 | PF13895 | |
| Domain | GPS | 2.31e-03 | 35 | 141 | 3 | PF01825 | |
| Domain | PTPc | 2.51e-03 | 36 | 141 | 3 | SM00194 | |
| Domain | GPS | 2.51e-03 | 36 | 141 | 3 | PS50221 | |
| Domain | GPS | 2.71e-03 | 37 | 141 | 3 | IPR000203 | |
| Domain | Ubiquitin-rel_dom | 2.76e-03 | 184 | 141 | 6 | IPR029071 | |
| Domain | LAM_G_DOMAIN | 2.93e-03 | 38 | 141 | 3 | PS50025 | |
| Domain | TYR_PHOSPHATASE_PTP | 3.16e-03 | 39 | 141 | 3 | PS50055 | |
| Domain | Laminin_G_2 | 3.39e-03 | 40 | 141 | 3 | PF02210 | |
| Domain | PTPase_domain | 3.64e-03 | 41 | 141 | 3 | IPR000242 | |
| Domain | Y_phosphatase | 3.64e-03 | 41 | 141 | 3 | PF00102 | |
| Domain | EGF_CA | 4.10e-03 | 86 | 141 | 4 | PF07645 | |
| Domain | FA | 4.18e-03 | 13 | 141 | 2 | PF08736 | |
| Domain | FERM-adjacent | 4.18e-03 | 13 | 141 | 2 | IPR014847 | |
| Domain | FA | 4.18e-03 | 13 | 141 | 2 | SM01195 | |
| Domain | LamG | 4.45e-03 | 44 | 141 | 3 | SM00282 | |
| Domain | Dynein_heavy_chain_D4_dom | 4.85e-03 | 14 | 141 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 4.85e-03 | 14 | 141 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 4.85e-03 | 14 | 141 | 2 | IPR013602 | |
| Domain | DHC_N2 | 4.85e-03 | 14 | 141 | 2 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 4.85e-03 | 14 | 141 | 2 | IPR011704 | |
| Domain | MT | 4.85e-03 | 14 | 141 | 2 | PF12777 | |
| Domain | AAA_8 | 4.85e-03 | 14 | 141 | 2 | PF12780 | |
| Domain | AAA_5 | 4.85e-03 | 14 | 141 | 2 | PF07728 | |
| Domain | DHC_fam | 5.57e-03 | 15 | 141 | 2 | IPR026983 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL12A1 COL6A6 PSG1 PSG4 COL20A1 CAPN3 FBN1 PXDN ICAM5 LTBP2 MMP17 TNXB | 1.83e-06 | 258 | 119 | 12 | MM14572 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL12A1 COL6A6 COL20A1 CAPN3 FBN1 PXDN PTPRS ICAM5 LTBP2 MMP17 TNXB | 4.63e-05 | 300 | 119 | 11 | M610 |
| Pathway | REACTOME_REGULATION_OF_COMMISSURAL_AXON_PATHFINDING_BY_SLIT_AND_ROBO | 6.74e-05 | 10 | 119 | 3 | M27348 | |
| Pathway | REACTOME_ASPARTATE_AND_ASPARAGINE_METABOLISM | 1.22e-04 | 12 | 119 | 3 | MM15556 | |
| Pathway | WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM | 1.49e-04 | 60 | 119 | 5 | M40048 | |
| Pathway | REACTOME_GLUTATHIONE_SYNTHESIS_AND_RECYCLING | 3.03e-04 | 16 | 119 | 3 | MM14680 | |
| Pubmed | 2.13e-09 | 162 | 148 | 10 | 25826454 | ||
| Pubmed | 7.55e-08 | 3 | 148 | 3 | 37349952 | ||
| Pubmed | Biochemical characterization of human glutamate carboxypeptidase III. | 7.55e-08 | 3 | 148 | 3 | 17241121 | |
| Pubmed | Molecular evolution of the transferrin receptor/glutamate carboxypeptidase II family. | 7.55e-08 | 3 | 148 | 3 | 17160644 | |
| Pubmed | 7.55e-08 | 3 | 148 | 3 | 38377674 | ||
| Pubmed | Molecular identification of β-citrylglutamate hydrolase as glutamate carboxypeptidase 3. | 7.55e-08 | 3 | 148 | 3 | 21908619 | |
| Pubmed | Different gamma-glutamyl transpeptidase mRNAs are expressed in human liver and kidney. | 7.55e-08 | 3 | 148 | 3 | 2573352 | |
| Pubmed | Role of neuropilin-2 in the ipsilateral growth of midbrain dopaminergic axons. | 2.18e-07 | 13 | 148 | 4 | 23534961 | |
| Pubmed | Evidence for the existence of two Robo3 isoforms with divergent biochemical properties. | 3.01e-07 | 4 | 148 | 3 | 16226035 | |
| Pubmed | 7.50e-07 | 5 | 148 | 3 | 23615310 | ||
| Pubmed | 7.50e-07 | 5 | 148 | 3 | 11003618 | ||
| Pubmed | 7.50e-07 | 5 | 148 | 3 | 10392451 | ||
| Pubmed | 7.50e-07 | 5 | 148 | 3 | 19850887 | ||
| Pubmed | Reversible skeletal abnormalities in gamma-glutamyl transpeptidase-deficient mice. | 7.50e-07 | 5 | 148 | 3 | 12810527 | |
| Pubmed | Growth retardation and cysteine deficiency in gamma-glutamyl transpeptidase-deficient mice. | 7.50e-07 | 5 | 148 | 3 | 8755578 | |
| Pubmed | Reproductive defects in gamma-glutamyl transpeptidase-deficient mice. | 7.50e-07 | 5 | 148 | 3 | 11089562 | |
| Pubmed | 7.50e-07 | 5 | 148 | 3 | 26977590 | ||
| Pubmed | Gamma-glutamyl transferase deficiency results in lung oxidant stress in normoxia. | 7.50e-07 | 5 | 148 | 3 | 12225953 | |
| Pubmed | 7.50e-07 | 5 | 148 | 3 | 7775425 | ||
| Pubmed | 7.50e-07 | 5 | 148 | 3 | 9139708 | ||
| Pubmed | 7.50e-07 | 5 | 148 | 3 | 20622017 | ||
| Pubmed | Accelerated methylmercury elimination in gamma-glutamyl transpeptidase-deficient mice. | 7.50e-07 | 5 | 148 | 3 | 9546365 | |
| Pubmed | 7.50e-07 | 5 | 148 | 3 | 7485380 | ||
| Pubmed | Accumulation of DNA damage in the organs of mice deficient in gamma-glutamyltranspeptidase. | 7.50e-07 | 5 | 148 | 3 | 10751614 | |
| Pubmed | Type VI RNA is the major gamma-glutamyl transpeptidase RNA in the mouse small intestine. | 7.50e-07 | 5 | 148 | 3 | 7523374 | |
| Pubmed | Cardio-reno-hepatic interactions in acute heart failure: the role of γ-glutamyl transferase. | 7.50e-07 | 5 | 148 | 3 | 24698228 | |
| Pubmed | Midbrain dopaminergic axons are guided longitudinally through the diencephalon by Slit/Robo signals. | 7.50e-07 | 5 | 148 | 3 | 21118670 | |
| Pubmed | 7.50e-07 | 5 | 148 | 3 | 10474818 | ||
| Pubmed | Lung lining fluid glutathione attenuates IL-13-induced asthma. | 7.50e-07 | 5 | 148 | 3 | 18063838 | |
| Pubmed | 7.50e-07 | 5 | 148 | 3 | 10940879 | ||
| Pubmed | Cataract development in gamma-glutamyl transpeptidase-deficient mice. | 7.50e-07 | 5 | 148 | 3 | 11095909 | |
| Pubmed | 7.50e-07 | 5 | 148 | 3 | 7641802 | ||
| Pubmed | 7.50e-07 | 5 | 148 | 3 | 9627710 | ||
| Pubmed | 7.50e-07 | 5 | 148 | 3 | 12453183 | ||
| Pubmed | 7.50e-07 | 5 | 148 | 3 | 2891746 | ||
| Pubmed | 7.50e-07 | 5 | 148 | 3 | 28660214 | ||
| Pubmed | Bleomycin-induced pulmonary fibrosis is attenuated in gamma-glutamyl transpeptidase-deficient mice. | 7.50e-07 | 5 | 148 | 3 | 12468440 | |
| Pubmed | Cloning of cDNA and genomic structure of the mouse gamma-glutamyl transpeptidase-encoding gene. | 7.50e-07 | 5 | 148 | 3 | 8566783 | |
| Pubmed | 7.50e-07 | 5 | 148 | 3 | 30591459 | ||
| Pubmed | 7.50e-07 | 5 | 148 | 3 | 11795900 | ||
| Pubmed | Inhibiting lung lining fluid glutathione metabolism with GGsTop as a novel treatment for asthma. | 7.50e-07 | 5 | 148 | 3 | 25132819 | |
| Pubmed | Characterization of the dwg mutations: dwg and dwg(Bayer) are new mutant alleles of the Ggt1 gene. | 7.50e-07 | 5 | 148 | 3 | 19760322 | |
| Pubmed | 9.06e-07 | 175 | 148 | 8 | 28071719 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | RALGAPA1 NUMBL FOLH1 FRMPD1 PEPD ADGRV1 UBN2 NDUFS3 EHD3 FARP2 PARP10 NCOR2 PWWP2B PXDN DPP9 PTPRG SUGP2 PTPRS NAT10 FOLH1B GPT2 | 1.46e-06 | 1489 | 148 | 21 | 28611215 |
| Pubmed | 1.50e-06 | 6 | 148 | 3 | 14634009 | ||
| Pubmed | Six mRNAs with different 5' ends are encoded by a single gamma-glutamyltransferase gene in mouse. | 1.50e-06 | 6 | 148 | 3 | 8101000 | |
| Pubmed | Autocrine/juxtaparacrine regulation of axon fasciculation by Slit-Robo signaling. | 1.50e-06 | 6 | 148 | 3 | 22306607 | |
| Pubmed | Mapping of human gamma-glutamyl transpeptidase genes on chromosome 22 and other human autosomes. | 1.50e-06 | 6 | 148 | 3 | 8104871 | |
| Pubmed | 1.50e-06 | 6 | 148 | 3 | 11463821 | ||
| Pubmed | 1.50e-06 | 6 | 148 | 3 | 25326709 | ||
| Pubmed | 1.50e-06 | 6 | 148 | 3 | 12163373 | ||
| Pubmed | Robo2 Receptor Gates the Anatomical Divergence of Neurons Derived From a Common Precursor Origin. | 1.50e-06 | 6 | 148 | 3 | 34249921 | |
| Pubmed | 1.50e-06 | 6 | 148 | 3 | 22242126 | ||
| Pubmed | 1.50e-06 | 6 | 148 | 3 | 17363454 | ||
| Pubmed | 1.50e-06 | 6 | 148 | 3 | 8663190 | ||
| Pubmed | Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation. | 2.61e-06 | 7 | 148 | 3 | 32284594 | |
| Pubmed | 2.61e-06 | 7 | 148 | 3 | 36685533 | ||
| Pubmed | 2.61e-06 | 7 | 148 | 3 | 27775020 | ||
| Pubmed | Defective epidermal growth factor gene expression in mice with polycystic kidney disease. | 2.61e-06 | 7 | 148 | 3 | 1968405 | |
| Pubmed | Characterization of cDNA encoding novel pregnancy-specific glycoprotein variants. | 2.61e-06 | 7 | 148 | 3 | 7794280 | |
| Pubmed | 3.41e-06 | 95 | 148 | 6 | 20843830 | ||
| Pubmed | Slit2 and Robo3 modulate the migration of GnRH-secreting neurons. | 4.16e-06 | 8 | 148 | 3 | 22912413 | |
| Pubmed | Robo4 is a vascular-specific receptor that inhibits endothelial migration. | 4.16e-06 | 8 | 148 | 3 | 12941633 | |
| Pubmed | 6.23e-06 | 9 | 148 | 3 | 22806432 | ||
| Pubmed | Collaborative and specialized functions of Robo1 and Robo2 in spinal commissural axon guidance. | 6.23e-06 | 9 | 148 | 3 | 20631173 | |
| Pubmed | 8.87e-06 | 10 | 148 | 3 | 23863468 | ||
| Pubmed | 8.87e-06 | 10 | 148 | 3 | 25033181 | ||
| Pubmed | Molecular mechanisms controlling midline crossing by precerebellar neurons. | 1.22e-05 | 11 | 148 | 3 | 18562598 | |
| Pubmed | Knockdown of slit signaling during limb development leads to a reduction in humerus length. | 1.22e-05 | 11 | 148 | 3 | 33347679 | |
| Pubmed | 1.22e-05 | 11 | 148 | 3 | 11804571 | ||
| Pubmed | 1.22e-05 | 11 | 148 | 3 | 28970231 | ||
| Pubmed | Robo2 is required for Slit-mediated intraretinal axon guidance. | 1.62e-05 | 12 | 148 | 3 | 19782674 | |
| Pubmed | 1.62e-05 | 12 | 148 | 3 | 20852008 | ||
| Pubmed | 1.62e-05 | 12 | 148 | 3 | 11830575 | ||
| Pubmed | Sim1 and Sim2 are required for the correct targeting of mammillary body axons. | 1.62e-05 | 12 | 148 | 3 | 16291793 | |
| Pubmed | 1.62e-05 | 12 | 148 | 3 | 19906969 | ||
| Pubmed | TPP2 DSCAM NUMBL CENPE DPYSL4 ZNFX1 UBN2 EHD3 NCOR2 PTPRS ICAM5 NAT10 PPP1R3F FRMPD3 EPB41L2 | 1.66e-05 | 963 | 148 | 15 | 28671696 | |
| Pubmed | 1.67e-05 | 36 | 148 | 4 | 37497580 | ||
| Pubmed | RALGAPA1 ADGRV1 ANKLE2 TIAM2 SULF2 AMIGO3 CCT5 NBEAL2 DDHD1 NAT10 CNTNAP2 | 1.78e-05 | 529 | 148 | 11 | 14621295 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 20068157 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 22826604 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 31008488 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 25180444 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 28973045 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 25872793 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 27091009 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 35584682 | ||
| Pubmed | Silencing of miRNA-218 promotes migration and invasion of breast cancer via Slit2-Robo1 pathway. | 1.80e-05 | 2 | 148 | 2 | 22898079 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 33281191 | ||
| Pubmed | Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. | 1.80e-05 | 2 | 148 | 2 | 8417812 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 12712410 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 23438940 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 21199427 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 16636676 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 31393085 | ||
| Pubmed | Slit2 and Robo1 induce opposing effects on metastasis of hepatocellular carcinoma Sk-hep-1 cells. | 1.80e-05 | 2 | 148 | 2 | 27176045 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 34414975 | ||
| Pubmed | FUT2: filling the gap between genes and environment in Behçet's disease? | 1.80e-05 | 2 | 148 | 2 | 24326010 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 25280803 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 27431199 | ||
| Cytoband | 7q35 | 3.11e-05 | 55 | 148 | 4 | 7q35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q35 | 6.40e-05 | 66 | 148 | 4 | chr7q35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q11 | 6.67e-04 | 12 | 148 | 2 | chr16q11 | |
| GeneFamily | Fibronectin type III domain containing | 3.18e-06 | 160 | 101 | 8 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.33e-06 | 161 | 101 | 8 | 593 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 8.55e-06 | 50 | 101 | 5 | 1293 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 2.70e-05 | 11 | 101 | 3 | 1315 | |
| GeneFamily | CD molecules|Gamma-glutamyltransferases | 4.65e-05 | 13 | 101 | 3 | 564 | |
| GeneFamily | CTAGE family | 7.33e-05 | 15 | 101 | 3 | 907 | |
| GeneFamily | Immunoglobulin like domain containing | 1.05e-04 | 193 | 101 | 7 | 594 | |
| GeneFamily | SINE class homeoboxes | 4.57e-04 | 6 | 101 | 2 | 525 | |
| GeneFamily | RNA binding motif containing|Serine and arginine rich splicing factors | 1.97e-03 | 12 | 101 | 2 | 737 | |
| GeneFamily | Collagens | 2.16e-03 | 46 | 101 | 3 | 490 | |
| GeneFamily | Dyneins, axonemal | 3.98e-03 | 17 | 101 | 2 | 536 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 3.98e-03 | 17 | 101 | 2 | 684 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 6.00e-03 | 66 | 101 | 3 | 722 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 6.05e-03 | 21 | 101 | 2 | 813 | |
| GeneFamily | GCN5 related N-acetyltransferases | 7.87e-03 | 24 | 101 | 2 | 1134 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 8.53e-03 | 25 | 101 | 2 | 775 | |
| Coexpression | NABA_CORE_MATRISOME | COL12A1 COL6A6 COL20A1 PAPLN SLIT2 CILP2 FBN1 PXDN LTBP2 TNXB | 3.14e-06 | 270 | 147 | 10 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | COL12A1 COL6A6 COL20A1 PAPLN SLIT2 CILP2 FBN1 PXDN LTBP2 TNXB | 3.69e-06 | 275 | 147 | 10 | M5884 |
| Coexpression | CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN | 8.04e-06 | 179 | 147 | 8 | M16932 | |
| Coexpression | GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_UP | 1.74e-05 | 199 | 147 | 8 | M3262 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.64e-09 | 175 | 148 | 9 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.36e-08 | 187 | 148 | 9 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.63e-08 | 191 | 148 | 9 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.71e-08 | 192 | 148 | 9 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.71e-08 | 192 | 148 | 9 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.96e-08 | 195 | 148 | 9 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.96e-08 | 195 | 148 | 9 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.04e-08 | 196 | 148 | 9 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.14e-08 | 197 | 148 | 9 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.23e-08 | 198 | 148 | 9 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 2.33e-08 | 199 | 148 | 9 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.43e-08 | 200 | 148 | 9 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.43e-08 | 200 | 148 | 9 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 6.31e-08 | 159 | 148 | 8 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.79e-07 | 182 | 148 | 8 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-07 | 186 | 148 | 8 | 5784d255e9ca449d375d81938d0fbbd8a7eb44f6 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.20e-07 | 187 | 148 | 8 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-07 | 187 | 148 | 8 | 3ae3b8de1a195d4d5057cf3c64fcdb5f48681ce5 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 2.48e-07 | 190 | 148 | 8 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.80e-07 | 193 | 148 | 8 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 2.80e-07 | 193 | 148 | 8 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 3.02e-07 | 195 | 148 | 8 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 3.02e-07 | 195 | 148 | 8 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 3.27e-07 | 197 | 148 | 8 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 3.40e-07 | 198 | 148 | 8 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 3.40e-07 | 198 | 148 | 8 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-07 | 199 | 148 | 8 | 7ed541309808f15d65a9c4b26be2050e077539e6 | |
| ToppCell | PCW_10-12-Mesenchymal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.53e-07 | 199 | 148 | 8 | a09292de4c4447b8eee55d401808e43b817321cc | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary-EC_aerocyte_capillary_L.2.0.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.67e-07 | 200 | 148 | 8 | 3767abc75176779198505ebc6967d55ce322d9fe | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.67e-07 | 200 | 148 | 8 | e0a003d2a5fd6adfcb817c9bc5dceb9c79e7491b | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.67e-07 | 200 | 148 | 8 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.67e-07 | 200 | 148 | 8 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.67e-07 | 200 | 148 | 8 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.67e-07 | 200 | 148 | 8 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.67e-07 | 200 | 148 | 8 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Influenza_Severe-Treg|World / Disease group and Cell class | 6.86e-07 | 149 | 148 | 7 | 3250bb668319139451c31aa496b3ca1ed6750ce4 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Col23a1_Adamts2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.53e-06 | 168 | 148 | 7 | 3fe432267656aff81b6d92c18d1b6fc0cde73d6a | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-06 | 169 | 148 | 7 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.01e-06 | 175 | 148 | 7 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | droplet-Kidney-nan-21m-Endothelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-06 | 179 | 148 | 7 | ba38177ffcf3a20f02afeeaaa91bc8eab8d1ac05 | |
| ToppCell | droplet-Kidney-nan-21m-Endothelial-kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-06 | 179 | 148 | 7 | d121351b4c3b91108e6c5753d18a44d676f38d4c | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 2.34e-06 | 179 | 148 | 7 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Mac-Cycling_Myeloid-Mac|lymph-node_spleen / Manually curated celltypes from each tissue | 2.61e-06 | 182 | 148 | 7 | 84018a84e1aa52fa52ccfc26db9cd1fb6d535b31 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.71e-06 | 183 | 148 | 7 | 764ea07621f77fbd13a877aed5806ae2b3dfb43e | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.71e-06 | 183 | 148 | 7 | ce8be9418b473ea94ec806edc7a2078cc30c1703 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.71e-06 | 183 | 148 | 7 | 38a54216458ad57f356bb4ddf272e1af8036ddeb | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.71e-06 | 183 | 148 | 7 | 06a68fa2be36448064f4668be24a5b85ad85c6e8 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-06 | 184 | 148 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.81e-06 | 184 | 148 | 7 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-06 | 184 | 148 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-06 | 184 | 148 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|kidney / Disease (COVID-19 only), tissue and cell type | 2.81e-06 | 184 | 148 | 7 | dc71f22583fc54b89b242cbb602f4bbe86f576ec | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.91e-06 | 185 | 148 | 7 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.01e-06 | 186 | 148 | 7 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.12e-06 | 187 | 148 | 7 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 3.12e-06 | 187 | 148 | 7 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.23e-06 | 188 | 148 | 7 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.35e-06 | 189 | 148 | 7 | eccf3d49354a67c94f1ed7c15a98a48a5e8e2ed0 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.35e-06 | 189 | 148 | 7 | 40764f461b8aa1d3a2c5a30590b7fb9307d47d09 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.47e-06 | 190 | 148 | 7 | a90a38fccdbf75a286b4d258fc54920c02b282f7 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.59e-06 | 191 | 148 | 7 | 5271198116343c07202649889057e5774d7fdde3 | |
| ToppCell | wk_15-18-Endothelial-Lymph_endothelial-Intermediate_lymphatic_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.59e-06 | 191 | 148 | 7 | d25ac3206fe205a100cfee26431ff32c14c1938f | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 3.59e-06 | 191 | 148 | 7 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 3.72e-06 | 192 | 148 | 7 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.85e-06 | 193 | 148 | 7 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 3.85e-06 | 193 | 148 | 7 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 3.85e-06 | 193 | 148 | 7 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 3.85e-06 | 193 | 148 | 7 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 3.98e-06 | 194 | 148 | 7 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.98e-06 | 194 | 148 | 7 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-06 | 194 | 148 | 7 | bc945450b350f597c3ff910d3a14a533d90086a8 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.12e-06 | 195 | 148 | 7 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.12e-06 | 195 | 148 | 7 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 4.12e-06 | 195 | 148 | 7 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 4.12e-06 | 195 | 148 | 7 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.26e-06 | 196 | 148 | 7 | 49cc0a2b9739abad61dff7292ea0b14d28ff35c4 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.26e-06 | 196 | 148 | 7 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.26e-06 | 196 | 148 | 7 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.26e-06 | 196 | 148 | 7 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.40e-06 | 197 | 148 | 7 | 3bb92dd8a94e2be3b7fe51c9a21b241215477ac7 | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.40e-06 | 197 | 148 | 7 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.40e-06 | 197 | 148 | 7 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.40e-06 | 197 | 148 | 7 | 17344464fdcc5ba0c03959696b97c195f11e644c | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 4.40e-06 | 197 | 148 | 7 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.40e-06 | 197 | 148 | 7 | 5b8d0d7116b20d8e27541e88ec80c9f1f477e384 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.55e-06 | 198 | 148 | 7 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | Sepsis-Int-URO-Others-RBC|Int-URO / Disease, condition lineage and cell class | 4.55e-06 | 198 | 148 | 7 | 29203aaa5c1844f72289e03f585cd5e7fc498a9a | |
| ToppCell | Sepsis-Int-URO-Others|Int-URO / Disease, condition lineage and cell class | 4.55e-06 | 198 | 148 | 7 | 67f721ea8e60042317ba12efd584f56b07cfb29d | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.55e-06 | 198 | 148 | 7 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.70e-06 | 199 | 148 | 7 | dc88ce36cc066eb6c28cfd5b9b60fe07f8cc7b53 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.70e-06 | 199 | 148 | 7 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.70e-06 | 199 | 148 | 7 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.70e-06 | 199 | 148 | 7 | 21335475bbfbad8a6943b8076a6c1c67f3eec5d3 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Myofibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 4.86e-06 | 200 | 148 | 7 | e504570fd7eec1524c401b1cfa9d10822d80d994 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.86e-06 | 200 | 148 | 7 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 4.86e-06 | 200 | 148 | 7 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.86e-06 | 200 | 148 | 7 | a4ec0e80f5422b91b85264a9bb74568dd577e285 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.86e-06 | 200 | 148 | 7 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.86e-06 | 200 | 148 | 7 | 6316c288022719b9e6c4332c5cb9041e1188d0e8 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.86e-06 | 200 | 148 | 7 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| Drug | precocene I | 1.41e-05 | 8 | 146 | 3 | CID000028619 | |
| Drug | HMik | 2.11e-05 | 9 | 146 | 3 | CID000131744 | |
| Drug | 4-tert-butylthiazole | 4.08e-05 | 2 | 146 | 2 | CID000581111 | |
| Drug | cetefloxacin | 4.08e-05 | 2 | 146 | 2 | CID000065995 | |
| Drug | L-645,164 | 4.08e-05 | 2 | 146 | 2 | CID006439709 | |
| Drug | paeonoside | 4.08e-05 | 2 | 146 | 2 | CID000442924 | |
| Drug | S00305 | 4.08e-05 | 2 | 146 | 2 | CID006419754 | |
| Drug | 2-phenylthiazole | 4.08e-05 | 2 | 146 | 2 | CID000547494 | |
| Drug | BP 2-94 | 4.08e-05 | 2 | 146 | 2 | ctd:C106714 | |
| Drug | 1-fluorohexane | 4.08e-05 | 2 | 146 | 2 | CID000009760 | |
| Drug | kutkin | 4.08e-05 | 2 | 146 | 2 | ctd:C057463 | |
| Drug | Apiopeonoside | 4.08e-05 | 2 | 146 | 2 | CID000127509 | |
| Drug | 4-chlorobenzothioamide | 4.08e-05 | 2 | 146 | 2 | CID002734826 | |
| Drug | p-methoxythiobenzamide | 4.08e-05 | 2 | 146 | 2 | CID000736827 | |
| Drug | deoxoviroidin | 4.08e-05 | 2 | 146 | 2 | CID000156810 | |
| Drug | deoxoviroisin | 4.08e-05 | 2 | 146 | 2 | CID000156812 | |
| Drug | Memantine Hydrochloride [41100-52-1]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 4.14e-05 | 197 | 146 | 8 | 7354_UP | |
| Drug | Ciprofibrate [52214-84-3]; Up 200; 13.8uM; HL60; HT_HG-U133A | 4.14e-05 | 197 | 146 | 8 | 6138_UP | |
| Drug | Pantothenic acid calcium salt monohydrate [63409-48-3]; Down 200; 8uM; PC3; HT_HG-U133A | 4.14e-05 | 197 | 146 | 8 | 4189_DN | |
| Drug | Clemizole hydrochloride [1163-36-6]; Up 200; 11uM; MCF7; HT_HG-U133A | 4.30e-05 | 198 | 146 | 8 | 4695_UP | |
| Drug | Orphenadrine hydrochloride [341-69-5]; Down 200; 13uM; MCF7; HT_HG-U133A | 4.30e-05 | 198 | 146 | 8 | 3883_DN | |
| Drug | Dipyridamole [58-32-2]; Up 200; 8uM; MCF7; HT_HG-U133A | 4.30e-05 | 198 | 146 | 8 | 5617_UP | |
| Drug | Trimipramine maleate salt [521-78-8]; Up 200; 9.8uM; HL60; HT_HG-U133A | 4.30e-05 | 198 | 146 | 8 | 3004_UP | |
| Drug | 2-acetylaminofluorene | 5.06e-05 | 262 | 146 | 9 | CID000005897 | |
| Drug | sulfobromophthalein | 5.38e-05 | 103 | 146 | 6 | CID000005345 | |
| Drug | L-Alanine | 7.05e-05 | 13 | 146 | 3 | DB00160 | |
| Drug | diphenaldehyde | 7.05e-05 | 13 | 146 | 3 | CID000014585 | |
| Drug | 2-chloro-1,1-difluoroethene | 7.05e-05 | 13 | 146 | 3 | CID000009664 | |
| Disease | aflatoxins-related hepatocellular carcinoma (biomarker_via_orthology) | 3.69e-06 | 7 | 141 | 3 | DOID:5022 (biomarker_via_orthology) | |
| Disease | alcohol dependence (biomarker_via_orthology) | 5.88e-06 | 8 | 141 | 3 | DOID:0050741 (biomarker_via_orthology) | |
| Disease | endoplasmic reticulum resident protein 29 measurement | 5.71e-05 | 16 | 141 | 3 | EFO_0020346 | |
| Disease | hereditary spastic paraplegia 28 (implicated_via_orthology) | 6.78e-05 | 3 | 141 | 2 | DOID:0110779 (implicated_via_orthology) | |
| Disease | Weill-Marchesani syndrome | 6.78e-05 | 3 | 141 | 2 | C0265313 | |
| Disease | hereditary spastic paraplegia 54 (implicated_via_orthology) | 6.78e-05 | 3 | 141 | 2 | DOID:0110806 (implicated_via_orthology) | |
| Disease | Weill-Marchesani Syndrome, Autosomal Dominant | 6.78e-05 | 3 | 141 | 2 | C1869115 | |
| Disease | Weill-Marchesani Syndrome, Autosomal Recessive | 6.78e-05 | 3 | 141 | 2 | C1869114 | |
| Disease | cD177 antigen measurement | 8.27e-05 | 18 | 141 | 3 | EFO_0021866 | |
| Disease | Weill-Marchesani syndrome | 1.35e-04 | 4 | 141 | 2 | cv:C0265313 | |
| Disease | trichloroethylene-induced hypersensitivity | 1.35e-04 | 4 | 141 | 2 | EFO_0007685 | |
| Disease | Weill-Marchesani syndrome (is_implicated_in) | 1.35e-04 | 4 | 141 | 2 | DOID:0050475 (is_implicated_in) | |
| Disease | Colorectal Carcinoma | SRSF6 FOLH1 PARP8 MCF2L2 CUBN F5 TOMM40L PTPRS ICAM5 ABCB11 ACIN1 SMAD4 | 1.46e-04 | 702 | 141 | 12 | C0009402 |
| Disease | urate measurement, spine bone mineral density | 1.73e-04 | 58 | 141 | 4 | EFO_0004531, EFO_0007701 | |
| Disease | serum metabolite measurement | RALGAPA1 NAALAD2 TRIM4 FOLH1 REV3L PKD1L2 GGT1 SLIT2 CEP89 OASL BHMT2 LSAMP FUT2 EXOSC4 | 1.82e-04 | 945 | 141 | 14 | EFO_0005653 |
| Disease | level of N-sulphoglucosamine sulphohydrolase in blood serum | 2.25e-04 | 5 | 141 | 2 | OBA_2043486 | |
| Disease | serum gamma-glutamyl transferase measurement | ENTPD7 MAP1A PEPD GGT1 FARP2 NCOR2 NBEAL2 OASL ABCB11 ROBO1 RORC FUT2 MMP17 | 4.57e-04 | 914 | 141 | 13 | EFO_0004532 |
| Disease | flavin adenine dinucleotide (FAD) measurement | 4.69e-04 | 7 | 141 | 2 | EFO_0800177 | |
| Disease | hereditary lymphedema (is_implicated_in) | 4.69e-04 | 7 | 141 | 2 | DOID:0050580 (is_implicated_in) | |
| Disease | myoclonic-atonic epilepsy (implicated_via_orthology) | 4.69e-04 | 7 | 141 | 2 | DOID:0060475 (implicated_via_orthology) | |
| Disease | panhypopituitarism (is_implicated_in) | 4.69e-04 | 7 | 141 | 2 | DOID:9410 (is_implicated_in) | |
| Disease | trefoil factor 3 measurement | 4.69e-04 | 7 | 141 | 2 | EFO_0008304 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 5.18e-04 | 291 | 141 | 7 | EFO_0008317, EFO_0020946 | |
| Disease | basophil count | 5.45e-04 | 483 | 141 | 9 | EFO_0005090 | |
| Disease | visual epilepsy (implicated_via_orthology) | 5.73e-04 | 34 | 141 | 3 | DOID:11832 (implicated_via_orthology) | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 7.20e-04 | 147 | 141 | 5 | DOID:9352 (biomarker_via_orthology) | |
| Disease | uric acid measurement | NAALAD2 DSCAM PLEKHA6 ADGRV1 CUBN F5 FARP2 EPAS1 EPB41L2 PLAAT5 | 7.27e-04 | 610 | 141 | 10 | EFO_0004761 |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 7.49e-04 | 224 | 141 | 6 | EFO_0004574, EFO_0008317 | |
| Disease | mitral valve prolapse (is_implicated_in) | 7.98e-04 | 9 | 141 | 2 | DOID:988 (is_implicated_in) | |
| Disease | interleukin-36 alpha measurement | 7.98e-04 | 9 | 141 | 2 | EFO_0021851 | |
| Disease | liver cancer (is_marker_for) | 7.98e-04 | 9 | 141 | 2 | DOID:3571 (is_marker_for) | |
| Disease | non-receptor tyrosine-protein kinase TYK2 measurement | 9.95e-04 | 10 | 141 | 2 | EFO_0008251 | |
| Disease | cystic kidney disease (implicated_via_orthology) | 9.95e-04 | 10 | 141 | 2 | DOID:2975 (implicated_via_orthology) | |
| Disease | Pulmonary arterial hypertension | 9.95e-04 | 10 | 141 | 2 | C2973725 | |
| Disease | nose morphology measurement | 1.06e-03 | 329 | 141 | 7 | EFO_0007843 | |
| Disease | primary immunodeficiency disease (is_implicated_in) | 1.07e-03 | 42 | 141 | 3 | DOID:612 (is_implicated_in) | |
| Disease | polymyositis (is_marker_for) | 1.21e-03 | 11 | 141 | 2 | DOID:0080745 (is_marker_for) | |
| Disease | maleate measurement, Alpha ketoglutarate measurement, fumarate measurement | 1.21e-03 | 11 | 141 | 2 | EFO_0010457, EFO_0010480, EFO_0010509 | |
| Disease | Marfan Syndrome | 1.21e-03 | 11 | 141 | 2 | C0024796 | |
| Disease | visceral:gluteofemoral adipose tissue ratio measurement | 1.31e-03 | 45 | 141 | 3 | EFO_0803319 | |
| Disease | bilirubin measurement | 1.33e-03 | 442 | 141 | 8 | EFO_0004570 | |
| Disease | high density lipoprotein particle size measurement | 1.38e-03 | 170 | 141 | 5 | EFO_0008592 | |
| Disease | salicylurate measurement | 1.71e-03 | 13 | 141 | 2 | EFO_0010532 | |
| Disease | estradiol measurement | 1.95e-03 | 110 | 141 | 4 | EFO_0004697 | |
| Disease | complement C4 measurement | 1.99e-03 | 52 | 141 | 3 | EFO_0004984 | |
| Disease | eosinophil count | HLA-B PSG1 PARP8 ANKLE2 TFR2 EHD3 FARP2 NCOR2 CILP2 CELSR1 PXDN SLC45A3 LTBP2 MMP17 TNXB SMAD4 | 2.04e-03 | 1488 | 141 | 16 | EFO_0004842 |
| Disease | Small cell carcinoma of lung | 2.22e-03 | 54 | 141 | 3 | C0149925 | |
| Disease | serum albumin measurement | 2.23e-03 | 592 | 141 | 9 | EFO_0004535 | |
| Disease | visceral adipose tissue measurement | 2.26e-03 | 481 | 141 | 8 | EFO_0004765 | |
| Disease | Antithrombotic agent use measurement | 2.34e-03 | 55 | 141 | 3 | EFO_0009925 | |
| Disease | sex interaction measurement, inflammatory bowel disease | 2.34e-03 | 55 | 141 | 3 | EFO_0003767, EFO_0008343 | |
| Disease | Blood Coagulation Disorders | 2.60e-03 | 16 | 141 | 2 | C0005779 | |
| Disease | Idiopathic pulmonary arterial hypertension | 2.60e-03 | 16 | 141 | 2 | C3203102 | |
| Disease | thyroxine measurement, triiodothyronine measurement | 2.94e-03 | 17 | 141 | 2 | EFO_0005130, EFO_0008392 | |
| Disease | fatty liver disease (is_marker_for) | 2.94e-03 | 17 | 141 | 2 | DOID:9452 (is_marker_for) | |
| Disease | dermatomyositis (is_marker_for) | 2.94e-03 | 17 | 141 | 2 | DOID:10223 (is_marker_for) | |
| Disease | protein-glutamine gamma-glutamyltransferase e measurement | 3.00e-03 | 60 | 141 | 3 | EFO_0020690 | |
| Disease | Liver carcinoma | 3.11e-03 | 507 | 141 | 8 | C2239176 | |
| Disease | melanoma | 3.19e-03 | 126 | 141 | 4 | EFO_0000756 | |
| Disease | pulmonary surfactant-associated protein d measurement | 3.30e-03 | 18 | 141 | 2 | EFO_0020693 | |
| Disease | tropical spastic paraparesis | 3.30e-03 | 18 | 141 | 2 | EFO_0007527 | |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 3.44e-03 | 303 | 141 | 6 | EFO_0004612, EFO_0020945 | |
| Disease | choline measurement | 3.56e-03 | 130 | 141 | 4 | EFO_0010116 | |
| Disease | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | 3.67e-03 | 307 | 141 | 6 | EFO_0004612, EFO_0020946 | |
| Disease | hypertension | 3.67e-03 | 307 | 141 | 6 | EFO_0000537 | |
| Disease | angiopoietin-1 receptor measurement | 3.68e-03 | 19 | 141 | 2 | EFO_0010600 | |
| Disease | gluteofemoral adipose tissue measurement | 3.76e-03 | 132 | 141 | 4 | EFO_0803317 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 3.81e-03 | 215 | 141 | 5 | EFO_0008317, EFO_0008591 | |
| Disease | low density lipoprotein cholesterol measurement, physical activity | 3.92e-03 | 66 | 141 | 3 | EFO_0003940, EFO_0004611 | |
| Disease | colorectal adenoma (is_marker_for) | 4.07e-03 | 20 | 141 | 2 | DOID:0050860 (is_marker_for) | |
| Disease | urinary microalbumin measurement | 4.07e-03 | 20 | 141 | 2 | EFO_0010967 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 4.19e-03 | 220 | 141 | 5 | EFO_0004529, EFO_0008317 | |
| Disease | MHC class I polypeptide-related sequence A measurement | 4.27e-03 | 68 | 141 | 3 | EFO_0008233 | |
| Disease | glycine measurement | 4.30e-03 | 137 | 141 | 4 | EFO_0009767 | |
| Disease | triglyceride measurement, body fat percentage | 4.49e-03 | 21 | 141 | 2 | EFO_0004530, EFO_0007800 | |
| Disease | gastric ulcer | 4.49e-03 | 21 | 141 | 2 | EFO_0009454 | |
| Disease | venous thromboembolism, plasminogen activator inhibitor 1 measurement | 4.49e-03 | 21 | 141 | 2 | EFO_0004286, EFO_0004792 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 4.61e-03 | 225 | 141 | 5 | EFO_0008317, EFO_0010351 | |
| Disease | phospholipid measurement | 4.64e-03 | 140 | 141 | 4 | EFO_0004639 | |
| Disease | apolipoprotein B measurement | 4.69e-03 | 663 | 141 | 9 | EFO_0004615 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LTRDGPTIVHDEYGA | 1341 | P23470 | |
| ELDYHRGLLVDRPSE | 1091 | Q9UKV3 | |
| EDVAAYITRRDGGVP | 161 | Q8TD30 | |
| VARYIERRDGGIPAD | 136 | P24298 | |
| ITELIGYHPEELLGR | 261 | Q99814 | |
| GFERVGRELAHELGY | 561 | Q86XL3 | |
| AVGGTEHAYRPGRRV | 16 | Q9UHF1 | |
| RGEPSYDRLIDPHRA | 576 | Q8IX94 | |
| RGEPSYDRLIDPHRA | 576 | P0CG41 | |
| RGEPSYDRLIDPHRA | 576 | A4FU28 | |
| EGDTPLHDAVRLNRY | 251 | Q15327 | |
| LSYGAEDHRALEIPG | 131 | P22570 | |
| EVVYIPLHRDGTDGQ | 671 | Q8WXG9 | |
| GHAAEYVRPRVALIG | 351 | Q9Y2Z9 | |
| ERGTHEELLERKGVY | 636 | O95342 | |
| ELHREEQGSHRGEYP | 2891 | Q9NYQ6 | |
| LERPEEHLYALVGRS | 281 | Q86WK7 | |
| VHVGPRGSVRLLAEY | 301 | Q8TF44 | |
| DKEVPGHGRNRYDEI | 566 | Q8NCD3 | |
| PVRYLGHVEVEESRG | 81 | Q9Y6R0 | |
| VHDVGGYPEGVERID | 376 | P12955 | |
| YDIDVEAHDGPGLRA | 346 | Q9Y5G9 | |
| SVAVPGEIRGYELAH | 131 | A6NGU5 | |
| DRGREDSLPKGHVIY | 1256 | Q9Y618 | |
| RGVSGVDLYRSHIPL | 1616 | Q9Y618 | |
| VVYGPHEIRGSRARA | 51 | Q9NPD3 | |
| GPHAVSLREYGAIDD | 166 | Q8N3A8 | |
| ELDGQGARPHYTEER | 1711 | P78559 | |
| GREHFVYGEPRELLT | 261 | Q9UBF1 | |
| EDVLRIGGRYHGPTF | 426 | Q9NQZ7 | |
| GPPEYLGQRHRLEDE | 451 | Q16538 | |
| EESYGGRDQHDRPLV | 161 | A6NFK2 | |
| DLRGYGETDAPIHRQ | 126 | Q8IUS5 | |
| VEPDRYVILGGHRDS | 366 | Q04609 | |
| EDVGEYRPHHRVTEG | 751 | O43491 | |
| LTRELGGTLEYRHGQ | 181 | Q86YR7 | |
| LLLAERVHSGYEAPR | 311 | O15055 | |
| IEGLLRVAREHAGTY | 536 | Q9UMF0 | |
| GAVEPDRYVILGGHR | 56 | Q9HBA9 | |
| VVPTDGGRYDVHLGE | 81 | O94830 | |
| EHGGLAGPEQYRELR | 296 | Q9UBR4 | |
| RVLVLHPRGLEYSVE | 481 | Q8NA19 | |
| LLRVHGGDGAEVYID | 16 | Q9BSJ2 | |
| EGHFRVPALGYLDVR | 96 | Q6UWW0 | |
| RGADPVIGLYLVHRG | 71 | A4D2B8 | |
| YAHSIRVDGDIILGG | 36 | O00222 | |
| DVGPDGRLLRGHDQY | 126 | P01889 | |
| LSGGRVVRIAVHPDY | 621 | Q9H0A0 | |
| RRDGYFEGIEEDPIH | 1601 | Q96JM4 | |
| TVTLYGLDGEREPHH | 1411 | Q7Z442 | |
| ARDIHLTVEQRGYPD | 351 | Q15646 | |
| YELLFREGDHGREVG | 556 | Q13332 | |
| RTQREGPEEAEGLRY | 681 | Q16825 | |
| PEHVGEDLTRALGDY | 401 | P0CG20 | |
| EIRGYQRIADGSHVP | 236 | Q9Y236 | |
| RIYDGPSIHARLIGA | 1911 | O60494 | |
| NRLAEIHGVPRGLYD | 486 | O14531 | |
| QHDGLLEYGEEGLRR | 866 | Q93033 | |
| YHIRAIAEELAPERG | 296 | Q9H2M3 | |
| FHPTGDDRRLGELVV | 1121 | Q99715 | |
| TAVLPGLGRHTEYDV | 701 | Q9P218 | |
| PHHGVYSREEELLRE | 116 | Q86TI2 | |
| RYEDEECTLPIAGRH | 961 | P35555 | |
| REDRGGHSDDLYAVP | 146 | Q96ST8 | |
| GDHGIIRTLDLPIYV | 556 | P53621 | |
| TVRLDPRLYEGSHAD | 691 | Q5SYB0 | |
| QGRHLRGLLYDEIPV | 726 | Q5JV73 | |
| RPGTFVGVHVRRGDY | 191 | Q10981 | |
| EDGRIGERPEIIYHV | 456 | Q7Z388 | |
| PGRRISAEDGLKHEY | 696 | Q9UQ88 | |
| IEAEREAGVHFRPGY | 1641 | Q14767 | |
| PLHRYGVGEAAVGAE | 271 | Q9Y5N1 | |
| GDLIHNRLPDEYLRG | 526 | Q8N7U6 | |
| LGGTREPYNIDVDHR | 1091 | Q9UHC6 | |
| TRLGGPAARHRYEVV | 146 | Q8NEL9 | |
| EEFRSPPREGAYIHG | 4386 | Q9NYC9 | |
| TYPLARHDDGLLEVV | 466 | P52429 | |
| LGYSVSIPREADGIH | 976 | O94887 | |
| VRGHAYSVTGLDEVP | 331 | P20807 | |
| GVELLGVYERELARH | 1216 | Q8IVF4 | |
| EIRDRYGGIRSDPVT | 311 | Q00888 | |
| GDSEHEPVYRAELVG | 341 | Q6NUJ5 | |
| RDHLRGYIREIEATG | 1216 | Q02224 | |
| RHRGIDIYSVGIGDV | 1126 | A6NMZ7 | |
| GDDRIEPYIHEGDIL | 701 | Q92845 | |
| EIRDRYGGIRSDPVT | 311 | P11464 | |
| SVAVPGEIRGYELAH | 131 | P36268 | |
| RGPGHVLLRYDSAVD | 966 | Q53GL7 | |
| RDPRDHYDLLQRLGG | 11 | Q92918 | |
| ATGEEIYDVPGIRHV | 61 | O60469 | |
| EEDGGQYRIHVASRP | 131 | Q5QGT7 | |
| IVEHARGPRRDGSYG | 66 | Q08170 | |
| SEEGPETGYSLRRHV | 336 | Q8N3S3 | |
| RPEELRLRIYHGGVE | 216 | Q3MII6 | |
| GRGRLVVVSHEGYLS | 56 | A6NFQ2 | |
| RDPRGEYEEHLGILG | 1631 | P12259 | |
| EYEEHLGILGPIIRA | 1636 | P12259 | |
| IAHAPERRLTLGGIY | 66 | O00358 | |
| RHLTPTGREFEGEEE | 166 | Q13449 | |
| RGLPLHLDSVDAVYE | 376 | Q9ULZ9 | |
| HPDLRRILTDYGFEG | 181 | O75489 | |
| VETEEGIGYDFRRPL | 1956 | Q6ZNJ1 | |
| AEDEEGPRGHQALYR | 381 | Q8NGU9 | |
| REAGRAPGDAVHKIY | 416 | Q13485 | |
| HYVEAEKLRGRPLGA | 91 | Q15475 | |
| RGIHPIRIADGYEQA | 126 | P48643 | |
| HYDILEDRVPSGLIV | 231 | Q8NEM2 | |
| IVEHARGPRRDRDGY | 66 | Q13247 | |
| EIRDRYGGIRSDPVT | 311 | Q13046 | |
| AEIYGRIEREHQISP | 336 | Q9NZN3 | |
| RAEPGTEARRHYDEG | 306 | Q96JT2 | |
| DIGHRLEYGGLGREV | 11 | Q96DG6 | |
| RVLPFDPRGAGVYHE | 536 | Q8IUL8 | |
| LEAALRAEEPGGHAY | 876 | Q9Y2H5 | |
| RAEEPGGHAYETPRE | 881 | Q9Y2H5 | |
| GGHAYETPREEIARL | 886 | Q9Y2H5 | |
| ELGPVIRSGVYSHLE | 496 | Q6ZU65 | |
| DYRRGIIPTEFGDVL | 1916 | Q6GYQ0 | |
| HLEYSPERGKAEGRE | 201 | P51449 | |
| LLHIYGSTVDGVPRD | 791 | Q8IVF5 | |
| PCSEIHYDRIGGRDA | 186 | P49588 | |
| HLLAGLESDGYRGER | 416 | O60673 | |
| AALEEYGPELHVALR | 221 | Q9Y5W7 | |
| TILHYERGAEGDLAP | 251 | O95428 | |
| STGAEVVLYHLPREG | 236 | Q96DM3 | |
| GELPTGRYEIRSDHS | 296 | Q96MS0 | |
| LGEAEYLLLREPGHV | 21 | Q9NS62 | |
| YDVDHPGEADSVLRG | 191 | Q8IX01 | |
| YGLHEGRRLGPVSAV | 2591 | P22105 | |
| HGYGSCDEIPRVDLR | 1296 | Q92626 | |
| NIRVDPRGLREGLHY | 596 | P29144 | |
| DVLRREGYEVEHAPA | 341 | Q86V40 | |
| GARLDFVVRYETPEG | 256 | Q6ZSY5 | |
| EEITLHYARLGRGVE | 551 | Q6ZSY5 | |
| GDKDHIAVELYRGRV | 1201 | O94813 | |
| AYVEGSRSPHEGDLE | 341 | Q8IV63 | |
| RIVHGRKSRPDEGVY | 131 | Q9Y6N7 | |
| GHLTVDTYGRPILEV | 11 | Q9Y279 | |
| HYIEAEKLRGRPLGA | 91 | Q9NPC8 | |
| ERVQIVSAIGYPRGH | 1831 | Q9P2E3 | |
| LEGGEDPLYVARRLV | 526 | Q96S55 | |
| TVEVGRYKGRRPESH | 1211 | A7E2V4 | |
| LVLGGELVYHRRPGE | 176 | Q969M1 | |
| ELVYHRRPGEEGAIL | 181 | Q969M1 | |
| RPGDLIEIFRIGYEH | 131 | Q96KN8 | |
| PALHRVGVYLDRGTG | 441 | Q9C037 | |
| TVYQRVEGPRKGHLE | 21 | Q9UP52 | |
| LDFGRYGDVVLRHIG | 641 | Q9UP52 | |
| GVGYPSTERHIRDRL | 46 | O60384 | |
| AIEVDGRVYHVGLGD | 541 | Q8IWU5 | |
| TEGRIITVEDHYPQG | 526 | P51854 | |
| GPHLEYFVRLEVRRG | 156 | P07101 | |
| SVAVPGEIRGYELAH | 131 | P19440 | |
| VEPDRYVILGGHRDS | 356 | Q9Y3Q0 | |
| SGREVEPGEDRTIRY | 201 | Q147X3 |